We are live on ! Find out more
ALPN

Alpine Immune Sciences Inc
ALPN

Delisted

ALPN was delisted on the 17th of May, 2024.

Back to rankings

58 hedge funds and large institutions have $55.4M invested in Alpine Immune Sciences Inc in 2016 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 19 increasing their positions, 11 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

73% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 11

2% less funds holding

Funds holding: 59 → 58 (-1)

11% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 9

46% less capital invested

Capital invested by funds: $103M → $55.4M (-$48M)

Holders
58
Holders Change
-1
Holders Change %
-1.69%
% of All Funds
1.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
19
Reduced
11
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$1.76M
2
SM
Sabby Management
Florida
+$793K
3
EAM
EverPoint Asset Management
Connecticut
+$626K
4
OM
Opaleye Management
Massachusetts
+$501K
5
BCM
Bridgeway Capital Management
Texas
+$375K

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$1.75M
2
MCM
Marsico Capital Management
Colorado
-$1.06M
3
SFM
Sphera Funds Management
Israel
-$759K
4
KCM
Kingdon Capital Management
New York
-$716K
5
SIM
Spark Investment Management
New York
-$332K
Name Holding Trade Value Shares
Change 		Change in
Stake
DM
1
Deerfield Management
New York
$15.6M – – –
Wellington Management Group
2
Wellington Management Group
Massachusetts
$7.3M -$308K -15,406 -3%
BI
3
BVF Inc
California
$6.45M +$1.76M +87,933 +29%
SM
4
Sabby Management
Florida
$2.76M +$793K +39,616 +31%
TM
5
Tiger Management
New York
$2.71M – – –
RCM
6
RA Capital Management
Massachusetts
$2.56M – – –
Jennison Associates
7
Jennison Associates
New York
$2.06M +$3.92K +196 +0.2%
Franklin Resources
8
Franklin Resources
California
$2.04M – – –
RSCM
9
Rock Springs Capital Management
Maryland
$2.04M – – –
Axa
10
Axa
France
$1.64M – – –
JP Morgan Chase
11
JP Morgan Chase
New York
$1.21M -$24K -1,201 -2%
Vanguard Group
12
Vanguard Group
Pennsylvania
$1.12M +$23K +1,148 +2%
KCM
13
Kingdon Capital Management
New York
$1.07M -$716K -35,778 -36%
WSA
14
Wall Street Associates
California
$711K – – –
BFA
15
BlackRock Fund Advisors
California
$546K -$36.2K -1,807 -5%
PA
16
Perceptive Advisors
New York
$521K – – –
EAM
17
EverPoint Asset Management
Connecticut
$521K +$626K +31,250 New
Fidelity Investments
18
Fidelity Investments
Massachusetts
$417K – – –
OM
19
Opaleye Management
Massachusetts
$417K +$501K +25,000 New
BIT
20
BlackRock Institutional Trust
California
$376K -$13.2K -660 -3%
SFM
21
Sphera Funds Management
Israel
$333K -$759K -37,912 -65%
BCM
22
Bridgeway Capital Management
Texas
$313K +$375K +18,750 New
Acadian Asset Management
23
Acadian Asset Management
Massachusetts
$299K -$19.9K -993 -5%
Alyeska Investment Group
24
Alyeska Investment Group
Illinois
$275K +$76.9K +3,841 +30%
Northern Trust
25
Northern Trust
Illinois
$214K – – –
1
2 3

ALPN Hedge Fund Activity: Q1 2016 in Review

58 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Alpine Immune Sciences Inc (ALPN) for Q1 2016, worth a combined $55.4M — down 46% from $103M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of ALPN and 8 opened new positions — a net loss of 1 holder — while 11 trimmed existing stakes and 19 added.

The largest buyer was BVF Inc, adding an estimated $1.76M. The largest seller was Goldman Sachs, cutting an estimated $1.75M.

  • 58 institutional investors held Alpine Immune Sciences Inc (ALPN) as of Q1 2016, down from 59 in Q4 2015.
  • Funds reported $55.4M of Alpine Immune Sciences Inc stock for Q1 2016, down 46% quarter-over-quarter.
  • 8 funds opened new Alpine Immune Sciences Inc positions in Q1 2016 and 9 closed out, a net change of -1 holder.
  • The largest Alpine Immune Sciences Inc buyer in Q1 2016 was BVF Inc, an estimated $1.76M added.
  • The largest Alpine Immune Sciences Inc seller in Q1 2016 was Goldman Sachs, an estimated $1.75M sold.

Based on aggregated 13F filings for Q1 2016.